Institute of Science and Ethics, University of Bonn, Bonner Talweg 57, 53113 Bonn, Germany.
J Perinat Med. 2021 Jul 6;49(8):945-948. doi: 10.1515/jpm-2021-0211. Print 2021 Oct 26.
The most well-known goal of non-invasive prenatal testing (NIPT) is still to determine whether or not a fetus has trisomy 21. Since women often terminate the pregnancy upon a positive result, there is concern that the use of NIPT contributes to discrimination against persons with disabilities. If this concern is justified, it could have an impact on the wider social acceptability of existing testing practices and their potential further expansion. This paper demonstrates four different versions of the discrimination worry, indicates how international policy papers have reacted to them, and identifies the ethically most relevant feature of the concern.
非侵入性产前检测（NIPT）最广为人知的目标仍然是确定胎儿是否患有 21 三体综合征。由于女性在阳性结果时往往会选择终止妊娠，因此有人担心 NIPT 的使用会导致对残疾人士的歧视。如果这种担忧是有道理的，那么它可能会对现有检测实践的更广泛的社会接受度及其进一步扩展产生影响。本文展示了对这种歧视担忧的四种不同表述，并指出了国际政策文件对这些担忧的反应，同时确定了该担忧在伦理上最相关的特征。
